Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
HPV Self-Collection
Hospital Authority, Hong Kong
Cervical Cancers
1 trial -
Hippocampal avoidance WBRT
Hospital Authority, Hong Kong
Metastatic Malignant Neoplasm to Brain
1 trial -
Hyaluronic Acid
Hospital Authority, Hong Kong
Shoulder Pain
1 trial -
Hydrochloride anlotinib
Zhongnan Hospital
Uterine Cervical Neoplasms
1 trial -
Hydrolysed Collagen (PROTÉGEN Plus)
Hospital Authority, Hong Kong
Fragility Fracture
1 trial -
Hypervision proton surgery
Hospital Authority, Hong Kong
Non-Small Cell Lung Cancer
1 trial -
Inactivated influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Hospital Authority, Hong Kong
CD30+ Peripheral T-cell Lymphoma
1 trial -
Intensive BP control
Chinese University of Hong Kong
Primary Hypertension
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial -
Ketogenic diet
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactose-free milk formula (Frisolac LF ®)
Hospital Authority, Hong Kong
Acute Gastroenteritis
1 trial -
Linked Color Imaging
Hospital Authority, Hong Kong
Early Gastric Cancer
1 trial -
Liquid Biopsy (SPOT-MAS Assay)
Hospital Authority, Hong Kong
Lung Cancer
1 trial -
LiveSpo Navax
Hospital Authority, Hong Kong
Acute Respiratory Tract Infections
1 trial -
Low dose midazolam
Hospital Authority, Hong Kong
Intubation
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
MR/PET
Hospital Authority, Hong Kong
Non-small Cell Lung Cancer
1 trial -
Magnesium Sulfate
Hospital Authority, Hong Kong
Myoma
1 trial -
Mailed nicotine replacement therapy (NRT)
The University of Hong Kong
Smoking Cessation
1 trial -
Medical treatment alone
Hospital Authority, Hong Kong
Intracranial Arteriosclerosis
1 trial -
Mesalazine
Chinese University of Hong Kong
Colitis, Ulcerative
1 trial -
Methotrexate
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources